Forte Steve
EVP, CHIEF FINANCIAL OFFICER at Repare Therapeutics Inc.
- Sold, on record
- $27k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Mar 12, 2025
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Repare Therapeutics Inc.EVP, CHIEF FINANCIAL OFFICER
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice Repare Therapeutics Inc.NoticeMay 10, 2023 2023
Filed to sell 20,000 shares ($207k)
Forte Steve, Officer, CFO
No 10b5-1 planFirst sale on recordFiling
- 2 Form 144 notice Repare Therapeutics Inc.NoticeMar 26, 2024 +321 days
Filed to sell 4,089 shares ($20k)
Forte Steve, Officer
10b5-1 planFirst sale on recordFiling
- 3 Form 4 sale Repare Therapeutics Inc.RoutineMar 27, 2024 +1 day
Sold 2,475 shares at $4.67 ($12k)
Forte Steve, EVP, CHIEF FINANCIAL OFFICER
10b5-1 planSold 5.5% of holdings ($209k position)42,212 shares leftFirst sale on recordFollows a Form 144Filing
- 4 Form 4 sale Repare Therapeutics Inc.RoutineApr 1, 2024 +5 days
Sold 1,614 shares at $4.62 ($7k)
Forte Steve, EVP, CHIEF FINANCIAL OFFICER
10b5-1 planSold 3.5% of holdings ($214k position)44,775 shares leftFollows a Form 144Filing
- 5 Form 4 sale Repare Therapeutics Inc.No planMar 12, 2025 +345 days
Sold 6,884 shares at $1.14 ($8k)
Forte Steve, EVP, CHIEF FINANCIAL OFFICER
No 10b5-1 planSold 11.2% of holdings ($70k position)54,786 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2025 | Mar 14, 2025 | Repare Therapeutics Inc. | EVP, CHIEF FINANCIAL OFFICER | Form 4 sale | 6,884 | $8k | 11.2% | No plan | SEC |
| Apr 1, 2024 | Apr 1, 2024 | Repare Therapeutics Inc. | EVP, CHIEF FINANCIAL OFFICER | Form 4 sale | 1,614 | $7k | 3.5% | Routine | SEC |
| Mar 27, 2024 | Mar 27, 2024 | Repare Therapeutics Inc. | EVP, CHIEF FINANCIAL OFFICER | Form 4 sale | 2,475 | $12k | 5.5% | Routine | SEC |
| Mar 26, 2024 | Mar 27, 2024 | Repare Therapeutics Inc. | Officer | Form 144 notice | 4,089 | $20k | Notice | SEC | |
| May 10, 2023 | May 10, 2023 | Repare Therapeutics Inc. | Officer, CFO | Form 144 notice | 20,000 | $207k | Notice | SEC |